renzapride (AZM 112)
/ Atlantic Healthcare
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 23, 2026
Prokinetic drugs that stimulate 5-HT4-serotonin receptors in the human atrium.
(PubMed, Naunyn Schmiedebergs Arch Pharmacol)
- "Several gastrointestinal drugs like bromopride, cinitapride, cisapride, clebopride, felcisetrag, metoclopramide, mosapride, naronapride, prucalopride, renzapride, tegaserod, velusetrag, and zacopride are probably agonists at 5-HT4-serotonin receptors in the intestine. We will present our view where there are remaining pre-clinical or clinical research needs. One may repurpose some of these drugs to act on cardiac 5-HT4-serotonin receptors and discuss for which indications this may offer additional benefits."
Journal • Review
1 to 1
Of
1
Go to page
1